PD-L1 negatively regulates the immune response by blocking the T cell receptor and CD28 signaling and thus is sufficient in immune evasion by suppressing anti-tumor immunity; therefore, dual-targeted CAR T-cells were effective toward c-Met+ PD-L1+ HCC cells and consisted of enhanced toxicity [92]. This evidence concerns the gene MET and hepatocellular carcinoma.